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Isolated cleft palate (CPO) is the rarest form of oral clefting. The incidence of CPO
varies substantially by geography from 1.3 to 25.3 per 10,000 live births, with the
highest rates in British Columbia, Canada and the lowest rates in Nigeria, Africa.
Stratified by ethnicity/race, the highest rates of CPO are observed in non-Hispanic
Whites and the lowest in Africans; nevertheless, rates of CPO are consistently higher
in females compared to males. Approximately fifty percent of cases born with cleft
palate occur as part of a known genetic syndrome or with another malformation
(e.g., congenital heart defects) and the other half occur as solitary defects, referred to
often as non-syndromic clefts. The etiology of CPO is multifactorial involving genetic
and environmental risk factors. Several animal models have yielded insight into the
molecular pathways responsible for proper closure of the palate, including the BMP,
TGF-β, and SHH signaling pathways. In terms of environmental exposures, only maternal
tobacco smoke has been found to be strongly associated with CPO. Some studies
have suggested that maternal glucocorticoid exposure may also be important. Clearly,
there is a need for larger epidemiologic studies to further investigate both genetic and
environmental risk factors and gene-environment interactions. In terms of treatment,
there is a need for long-term comprehensive care including surgical, dental and speech
pathology. Overall, five main themes emerge as critical in advancing research: (1)
monitoring of the occurrence of CPO (capacity building); (2) detailed phenotyping of the
severity (biology); (3) understanding of the genetic and environmental risk factors (primary
prevention); (4) access to early detection andmultidisciplinary treatment (clinical services);
and (5) understanding predictors of recurrence and possible interventions among families
with a child with CPO (secondary prevention).
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INTRODUCTION
Isolated cleft palate (CPO) is the least common form of oral
clefting (approximately 33% of all oral clefts), affecting 1 to 25 per
10,000 newborns worldwide. Because of the rarity of CPO and its
distinct embryologic origins and recurrence risks from cleft lip
with or without cleft palate (CL/P), most studies either exclude
CPO or conflate these cases with CL/P due to hypothesized
common genetic and epidemiologic risks, although no studies
to date have had sufficient power to evaluate these hypotheses.
Thus, our knowledge about whether the risk factors for CPO do
indeed differ from those of CL/P remains incomplete. Although
much remains to be confirmed in human studies, there is a wealth
of information from animal models on the molecular biological
pathways necessary for complete closure of the primary and
secondary palate during embryogenesis. In this article, we
summarize the results of epidemiologic population-based studies
and animal models to present a comprehensive review of the
anatomy and classification, descriptive epidemiology, molecular
biology, risk factors, treatment, and outcomes for children born
with a cleft palate.
ANATOMY, EMBRYOLOGY, AND
CLASSIFICATION
Anatomy
The human palate (Figure 1) consists of a bony hard palate and
fibromuscular soft palate. The hard palate is further divided into
primary and secondary portions. The primary palate lies anterior
to the incisive foramen, and the secondary palate lies posterior
separating the nasal passage from the pharynx (Wexler, 1997;
Friedman et al., 2010).
The soft palate, or velum, is a fibromuscular shelf forming
a sling posterior to the hard palate and consisting of five
pairs of muscles: the palatoglossus, palatopharyngeus, levator
veli palatini, tensor veli palatine, and musculus uvulae. The
palatoglossus and palatopharyngeus muscles are superficial on
the oral side and help draw the soft palate downward and lateral
pharyngeal walls inward. Deep within these muscles are the
musculus uvulae, which pull the uvula forward and upwards.
The tensor veli palatini tenses and depresses the soft palate while
opening the Eustachian tube. The levator veli palatini, the largest
muscle in the group, elevates the soft palate and secondarily
opens the Eustachian tube (Wexler, 1997).
Embryology
Embryonic development of the palate occurs between the 4th
and 12th to 13th weeks of life. During that time, the basic
morphology of the face is formed with the fusion of the five
basic facial prominences: the midline frontonasal and the paired
maxillary and mandibular prominences (Afshar et al., 2012).
The medial portion of the frontonasal prominence gives rise
to the primary palate, while the maxillary prominences create
the secondary palate. Each facial prominence consists of neural
crest cells, which are ectodermal-derived cells at the margins of
the neural folds bilaterally and the transitional area between the
neuroectoderm and epidermis, in segmental positions along the
FIGURE 1 | Subtypes and subclinical forms of cleft palate. (A) Normal lip
and palate. (B) Unilateral cleft palate. (C) Bilateral cleft palate. (D) Cleft uvula.
(E) Submucous cleft palate.
neural tube (Afshar et al., 2012). Neural crest cell migration into
the craniofacial and pharyngeal complexes is predetermined by
inductive events between the forebrain, midbrain, and hindbrain,
the timing and extent of which is dependent on a complex pattern
of gene signaling, including Hox, Ssh, Otx, Gsc, Dlx, Msx, Lhx,
and Prrx based on animal studies (Sperber, 2002a; Chai and
Maxson, 2006). Deficiencies in neural crest cell migration or
proliferation are the source of a diverse spectrum of craniofacial
malformations, including cleft palate (Hall, 1999; Eppley et al.,
2005).
The primary palate forms around developing olfactory
placodes with rapid proliferation of lateral epithelium and
underlying mesenchyme, controlled in part by FGF, BMP, SSH,
and retinoic acid (Mossey et al., 2009). Separation of the oral
and nasal cavities occurs with fusion of the frontonasal process
and maxillary processes; fusion requires coordinated growth
between the processes and apoptosis of the epithelium that forms
the transient nasal bridge (fin) between the paired processes
(Mangold et al., 2011). Clefting of the primary palate most
often occurs between the primary and secondary palates at
the incisive foramen that separates the lateral incisors and
canine teeth; initial mesenchymal deficiency, delayed ossification,
decreased premaxilla volume, increased apoptosis, or increased
bone resorption due to a lack of functional forces on the primary
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palate have been identified as sources of clefting (Siegel et al.,
1985, 1991; Mooney et al., 1992).
Closure and fusion of the secondary palate requires timed
interactions, movements, and apoptosis along the medial
margins of the palatal shelves (Zhou et al., 2013). Secondary
palate fusion occurs from anterior to posterior, beginning at
the incisive foramen and concluding with uvular fusion (Smith
et al., 2012). Starting at week 8, the palatal shelves rotate from
a vertical position surrounding the tongue and elevate into a
horizontal position (Sperber, 2002b). This movement is slightly
delayed in females (Burdi and Faist, 1967). After shelf rotation
and elevation, adhesive contact, seam fusion along the medial
edges, and apoptosis of the epithelium are critical for normal
secondary palatogenesis (Sperber, 2002b). As the secondary
palate closes, the mandibular prominences grow and the tongue
becomes positioned more anteriorly in the oral cavity (Diewert
and Lozanoff, 2002). Clefting of the secondary palate may arise
from failure of the palatal shelves to elevate, adhere or fuse,
which may be due to genetic, mechanical or teratogenic factors
that perturb the stepwise growth, rotation, and fusion of the
prominences (Afshar et al., 2012). Factors that have been shown
to impede palatal shelf contact include delayed shelf rotation
into the horizontal position, small palatal shelf size, deficient
extracellular matrix accumulation, delayed growth of mandibular
prominences, head extension (leading to an increase in the
vertical facial dimension), abnormal craniofacial morphology,
abnormal first arch development, increased tongue obstruction
of shelf movement secondary to mandibular retrognathia, and
amniotic sac rupture leading to severely constricted fetal head
and body posture (Diewert and Lozanoff, 2002; Johnston and
Bronsky, 2002).
Palatal clefts span many degrees of severity and can include
the soft palate, hard palate and alveolus (the bony ridge of
the maxilla or mandible that supports and contains teeth).
The degree of palate clefting is a consequence of the point in
fetal development at which formation was disrupted (Friedman
et al., 2010). Primary palate fusion is usually complete the
during the fourth to 8th week, while the secondary palate starts
forming during the 8th week, with completion by about the
12th week (Marazita and Mooney, 2004; van Aalst et al., 2008).
This difference in timing between the primary and secondary
palate is one reason for considering CL/P and CPO as different
developmental deformities. Additionally, the female palate is
known to close 1 week later than the male palate, increasing the
risk of cleft palate formation, and is a current hypothesis for
the higher frequency of cleft palate in females. Burdi and Silvey
demonstrated this by finding the critical week of palatal closure
to be the 7th week in males and 8th week in females (Burdi and
Silvey, 1969; van Aalst et al., 2008).
Classification
Clefts affecting the palate are grossly classified as unilateral
(incomplete vs. complete), bilateral (incomplete vs. complete),
or submucous. A number of descriptive classifications have been
presented. In 1931, Veau classified clefts into four groups: (1) soft
palate cleft only; (2) cleft of soft and hard palate; (3) unilateral
cleft lip and palate; (4) bilateral cleft lip and palate. However, this
classification does not address primary palate clefts or distinguish
incomplete vs. complete clefts of the lip and palate (Veau, 1931).
Kriens introduced a palindromic classification using the acronym
“LAHSHAL,” describing the bilateral anatomy of the lip (L),
alveolus (A), hard (H), and soft (S) palates from right to left. The
first character is for the patient’s right lip, and the last character is
for the patient’s left lip. The LAHSHAL code indicates complete
cleft with a capital letter and an incomplete cleft with a small
letter. For example, a complete right-sided unilateral cleft lip,
alveolus, hard and soft palate is “LAHS.” This is the system
currently used in the outcomes registry for the American Cleft
Palate and Craniofacial Association.
NON-SYNDROMIC vs. SYNDROMIC CLEFT
PALATE
Cleft palates can be divided into two groups: (1) syndromic CPO
is associated with additional structural abnormalities occurring
outside the region of the cleft (also called “nonisolated” cleft
palate) or with a syndrome with a known genetic etiology, and (2)
non-syndromic CPO is an isolated condition unassociated with
any recognizable anomalies (also known as “isolated” cleft palate;
Mai et al., 2014; Watkins et al., 2014). The proportion of oral
clefts with additional anomalies is more frequent for CPO than
for CL/P (Mossey et al., 2009). About 50% of CPO are associated
with another malformation syndrome, compared with less than
15% of CL/P (Shprintzen et al., 1985). The most commonly
associated anomalies associated with CPO are congenital heart
defects (31.1%), deformations (22.4%), hydrocephaly (11.2%),
urinary tract defects (9.7%), and polydactyly (9.2%; Mossey and
Catilla, 2003).
Originally, non-syndromic CPO was thought to be a distinct
condition with its own genetic etiology, separate from all forms
of syndromic CPO, partially due to the low occurrence of non-
syndromic and syndromic forms of CPO within the same family.
However, recent research has shown both conditions may be
opposite ends of a large spectrum of CPO, largely due to advances
in genome sequencing and recognition of subclinical phenotypes.
For CPO associated with a syndrome with a known genetic cause,
many of these syndromes were thought to have a set group of
physical features when first discovered. As genome sequencing
has become more common in the clinical setting, new cases
of these syndromes are now being diagnosed in patients who
have the genetic marker but do not always display all of the
characteristic features, and may display additional features as
well. In non-syndromic CPO, recent recognition of subclinical
phenotypes, such as bifid uvula and submucous cleft palate, has
led to an increase in the number of affected family members for
some patients, shedding light on possible inheritance patterns
(Reiter et al., 2012; Watkins et al., 2014). In both non-syndromic
and syndromic forms of CPO, the diagnostic criteria have been
reevaluated to include new associated features that were not
initially considered and subclinical forms that were not originally
diagnosed. Recent research has also shown that some genes
responsible for syndromic CPO may also be candidate genes
for non-syndromic CPO, further indicating that these conditions
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may represent different portions of a single spectrum (Stanier and
Moore, 2004).
MOLECULAR BIOLOGY OF
PALATOGENESIS
Palatal development in mammals is a complex process involving
a network of growth factors, cell-surface receptors, and signaling
molecules. The palatal shelves appear around week 6 during
gestation in humans (Chai and Maxson, 2006). They are
composed of cranial neural crest-derived mesenchymal cells
and mesoderm-derived endothelial cells, which together are
covered by pharyngeal ectoderm-derived epithelial cells (Iwata
et al., 2011; Hill et al., 2015). Normal development of the
palate depends on proper migration, growth, differentiation, and
apoptosis of these cells, and occurs in three major stages: vertical
growth of the shelves down toward the sides of the tongue,
elevation of the palatal shelves to acquire a horizontal position as
the mandible lengthens, and fusion of the palatal shelves to form
the transient midline epithelial seam, which ultimately undergoes
epithelial to mesenchymal transition (Mossey et al., 2009; Sasaki
et al., 2014). Cleft palate can arise due to an error in any of
these stages, which many studies have demonstrated in mouse
models. These defects can be grouped into five categories: failure
of palatal shelf formation, fusion of the palatal shelf with the
tongue or mandible, failure of palatal shelf elevation, failure of
palatal shelves to meet post-elevation, and persistence of the
medial edge epithelium (Chai and Maxson, 2006). However, it
should be noted mouse models are more likely to demonstrate
a cleft palate due to a smaller frontonasal prominence, making
these studies limited in their applicability to humans, as gene
mutations that cause CPO in mice may cause CL/P in humans.
Molecular heterogeneity along the anterior-posterior axis of
the palate has been shown in mouse models, as evidenced by
different gene expression, signaling pathways, and transcription
factors between the anterior hard palate and posterior soft palate
(Zhou et al., 2013). Additionally, specific gene mutations have
been found to only cause clefts in the anterior or posterior
palate. In the anterior palate, the associated genes are Msx1,
Bmp4, and Bmp2 in the bone morphogenetic pathways, Shh
and Spry2 in the sonic hedgehog (Shh) signaling pathway, Fgf10
and Fgf7 in the Fgf signaling pathway, the Shox2 network,
Efnb1 in Ephrin signaling, and the Tgf-β family. The genes
associated with the posterior palate areMeox2, Tbx22, and Barx1.
Loss of function of Shox2 results in an incomplete cleft of the
anterior palate but normal posterior palate development, while
mutations ofMSX1 in humans have been associated with isolated
non-syndromic cleft palate (Smith et al., 2012). Many of these
pathways are interrelated and mediate communication between
the mesenchyme and the epithelium; for example, the BMP and
FGF signaling pathways both utilize Shh signaling in the anterior
palate to regulate palatal growth (Chai and Maxson, 2006).
Msx1 expression in the anterior mesenchyme regulates Bmp4
expression, which regulates Shh expression in the epithelium.
Shh in turn regulates Bmp2 expression in the mesenchyme, and
Bmp2 expression regulatesmesenchymal cell proliferation (Smith
et al., 2012). FGF10 protein is expressed in the anterior palatal
mesenchyme, and upon binding to its receptor FGFR2 in the
palatal epithelium, induces Shh expression, forming a positive
feedback loop (Chai and Maxson, 2006; Zhou et al., 2013). Shh
functions to indirectly induce mesenchymal cell proliferation via
Bmp2, and convergence of the BMP and FGF pathways on Shh
expression in the anterior palatal epithelium controls anterior
palatal outgrowth (Chai and Maxson, 2006).
DESCRIPTIVE EPIDEMIOLOGY
Although the prevalence of CPO is unknown in some parts of the
world, current reported rates for various countries are shown in
Table 1. Prevalence of cleft palate varies greatly between certain
regions. The highest reported rates are in British Columbia (a
province of Canada), Finland, and Malta, with prevalence rates
of 25.31, 14.31, and 14.13 per 10,000 live births, respectively. The
lowest reported rates are in South Africa, Colombia, and Cuba,
with prevalences of 1.93, 1.69, and 1.35 per 10,000 live births,
respectively. In the U.S., the overall CPO prevalence is 5.9 per
10,000 lives births (Mai et al., 2014), and estimated to be 3.18 per
10,000 for non-syndromic CPO (Parker et al., 2010). Even though
most countries calculate the prevalence of CPO from only live
births, combined data from European registries for 1995–1399
reported 2.4% of babies with CPO were stillborn, and 8.1% were
from terminated pregnancies (Mossey et al., 2009). It should be
noted prevalence may be underestimated if using national birth
registry lists, as cleft palates often go undiagnosed in utero or at
birth due to their lack of external visibility (Cooper et al., 2006;
Mossey et al., 2009).
DISPARITIES IN RATES BY SEX AND
RACE/ETHNICITY
Cleft palate is more commonly reported in females than males,
but the exact reasons why are still incompletely understood.
The reported sex ratio of affected males to females by the
World Health Organization is 0.93 (CI 95%: 0.89–0.96) for
non-syndromic CPO (Mossey and Catilla, 2003). Female sex
hormones may play a role in increased clefting for both lips
and palates (Ross and Johnson, 1972; Miura et al., 1990), and
as already noted, the female palate closes 1 week later than that
of males. The suggested inheritance patterns for cleft palate are
autosomal dominant and X-linked recessive. Although it may
seem counterintuitive for an X-linked recessive condition to
appear more often in females, X-chromosome inactivation in
females in uteromay explain the broader spectrum of phenotypes
seen in females (Stanier and Moore, 2004; Jugessur et al., 2012).
Although there is a 50% chance the mutated allele will inactivate
in heterozygous females, leaving them affected less severely or
not at all, females also have twice the risk of inheriting a mutated
X-chromosome (Lidral et al., 2008).
Generally for all oral clefts, there are consistent patterns of
increased risk in Asians whereas the lowest rates are seen in
Africans (Mossey and Catilla, 2003). For CPO specifically, the
highest rates were observed in whites and certain peoples from
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TABLE 1 | Worldwide prevalence rates of cleft palate.
Country Rate per 10,000
(95% CI if available)
References
USA* 5.9 (5.7–6.0) Mai et al., 2014
California 5.81 (5.54–5.98) Saad et al., 2014
Kentucky 5.70 Human Genetics Programme, 2007
Alabama 5.37 Human Genetics Programme, 2007
Colorado 4.83 Human Genetics Programme, 2007
Hawaii 3.94 Human Genetics Programme, 2007
Rhode Island 2.22 Human Genetics Programme, 2007
Canada* 7.02 (6.58–7.47) Mossey and Catilla, 2003
British Columbia 25.31 Mossey and Catilla, 2003
Alberta 8.07 (6.70–9.63) Mossey and Catilla, 2003
Caribbean
Cuba 1.35 (0.95–1.87) Mossey and Catilla, 2003
Central America
Mexico 3.06 (2.46–3.76) Mossey and Catilla, 2003
Guatemala 4.7 Matute et al., 2014
South America
Paraguay 6.83 (3.39–12.23) Mossey and Catilla, 2003
Brazil 4.49 (3.65–5.47) Mossey and Catilla, 2003
Colombia 1.69 (0.16–6.16) Mossey and Catilla, 2003
European Union
Finland 14.31(13.12–15.58) Mossey and Catilla, 2003
Scotland 7.94 (5.95–10.39) Mossey and Catilla, 2003
Malta 14.13 (10.13–19.16) Mossey and Catilla, 2003
Africa
South Africa 1.93 (1.49–2.46) Mossey and Catilla, 2003
Nigeria 0.32 Butali et al., 2014a
South Asia
India 1.7 Mossey and Little, 2009
Nepal 3.5 Singh et al., 2012
East Asia
China 2.36 (1.98–2.78) Mossey and Catilla, 2003
2.6 (2.4–2.7) Cooper et al., 2006
Japan 4.54 (4.02–5.10) Mossey and Catilla, 2003
3.7 (3.2–4.1) Cooper et al., 2006
Australia 6.48 Mossey and Catilla, 2003
New Zealand 6.45 Mossey and Catilla, 2003
*Top 3 highest and lowest rates per available states/provinces are provided.
Canada and Northern European countries, while the lowest rates
were again seen in Africans (Mossey and Catilla, 2003). Within
the U.S., prevalence has been to shown to vary between different
ethnicities, with the highest rates amongst non-Hispanic whites
and American Indians or Alaska Natives and the lowest amongst
non-Hispanic blacks. A national estimate with pooled data from
29 states reported the prevalence for isolated cleft palate as 6.4
per 10,000 live births for non-Hispanic whites, 6.4 for American
Indians or Alaska Natives, 5.6 for Hispanics, 5.6 for Asians or
Pacific Islanders, and 4.4 for non-Hispanic blacks (American
Indian and Alaska Native groups may be skewed due to small
sample size) (Mai et al., 2014). Within the state of California,
different trends were shown, as prevalence rates were reported
TABLE 2 | Association between family history and risk of cleft palate.
Study Population Region RR (95% CI)
Sivertsen et al., 2008 Norway All first-degree relatives 56 (37.2–84.8)
Parents 54 (29.7–98.0)
Siblings 58 (37.2–84.8)
Grosen et al., 2010 Denmark All first-degree relatives 15 (13–17)
Parents 10 (7–14)
All Siblings 16 (13–20)
Offspring 20 (15–26)
as 7.60 per 10,000 live births for non-Hispanic whites, 4.90 for
Asian/Pacific Islanders, 4.79 for Hispanics, 4.12 for non-Hispanic
blacks, and 2.11 for Native Americans (Saad et al., 2014).
The size of the facial processesmay relate to cleft susceptibility,
as size of the frontonasal process contributes to its ability to
contact neighboring processes. Inherently smaller frontonasal
processes, as found in Asians because of the combination of a
smaller, flatter midface with a broader upper face, brachycephalic
head, and elliptical palate, may contribute to their relative higher
rates of clefting (Setó-Salvia and Stanier, 2014). Africans have
broader, larger noses which imply a larger frontonasal process
and larger palate; this may contribute to their lower clefting
frequency (Eppley et al., 2005).
GENETIC RISK FACTORS
CPO has been shown to have a strong genetic component based
on its high recurrence rate in families of affected individuals. In
population studies, the relative risk of recurrence of CPO among
first-degree relatives has been reported to be 56 times greater in
Norway and 15 times greater in Denmark than the risk for the
general population (Sivertsen et al., 2008; Grosen et al., 2010;
Table 2). Twin studies have also shown monozygotic twins are
more likely to both be affected by CPO than dizygotic twins. In
Denmark, research has shown probandwise concordance rates
of 33% for monozygotic twins and 7% for dizygotic. It was also
noted that CPO and CL/P never both appeared in one pair of
twins (Grosen et al., 2011).
Currently, over 400 syndromes are reported to include CPO
(Mossey et al., 2009). Syndromes including CPO that have been
traced to a known gene mutation are listed in Table 3, along with
their associated features. The most common form of syndromic
oral clefts is Van der Woude’s syndrome, which accounts for
2% of all CL/P cases and often presents with lower lip pits
(Kondo et al., 2002; Brito et al., 2012; Leslie and Marazita,
2013). Most syndromes involving oral clefts present as either
predominately CL/P or CPO, but Van der Woude’s commonly
shows both CL/P and CPO (Kondo et al., 2002). Mutations in
IRF6 cause Van der Woude’s, along with popliteal pterygium
(Leslie et al., 2015), and recent research suggests that mutations
surrounding the gene may be involved in non-syndromic cleft
palate (Zucchero et al., 2004; Rahimov et al., 2012; Pegelow
et al., 2014). Another common form of syndromic clefting is
DiGeorge (22q11.2 deletion) syndrome, which presents with
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TABLE 3 | List of syndromes with a cleft palate and attributed genes.
Syndrome Other associated features Prevalence Gene(s)
Abruzzo-Erickson† Coloboma, hypospadias, deafness, short stature, radial synostosis 4 cases reported‡ TBX22
Andersen§ Periodic paralysis, micrognathia, low-set ears, dental abnormalities, widely
spaced eyes
100 cases reported KCNJ2
Apert* Craniosynostosis, syndactyly, sunken face, beaked nose, hearing loss 1/65,000–88,000 FGFR2
Bamforth-Lazarus* Thyroid agenesis, choanal atresia 8 cases reported‡ FOXE1
CHARGE* Coloboma, heart defect, choanal atresia, retarded growth and
development, genital, and ear abnormalities (CP minor characteristic)
1/8500–10,000 CHD7
Cornelia de Lange* Slow growth, intellectual disability, skeletal abnormalities, low-set ears,
small and widely spaced teeth, small, and upturned nose
1/45,000–62,500‡ NIPBL, SMC1A,
SMC3
Craniofrontonasal§ Hypertelorism, brachycephaly, downslanting palpebral fissures, clefting of
nasal tip
Unknown EFNB1
Crouzon* Craniosynostosis, wide-set bulging eyes, shallow eye sockets,
strabismus, beaked nose, underdeveloped upper jaw (CP minor
characteristic)
0.9/100,000‡ FGFR2
Desmosterolosis§ Brain abnormalities, delayed speech and motor skills, muscle spasticity,
arthrogryposis, short stature, micrognathia
10 cases reported DHCR24
Diastrophic dysplasia§ Short stature, short arms and legs, early osteoarthritis, contractures,
clubfoot, hitchhiker thumbs, swelling of external ears
1/100,000 SLC26A2
DiGeorge* Heart abnormalities, breathing problems, kidney abnormalities, hearing
loss, short stature, developmental delays
1/4000 TBX1, COMT
Hereditary lymphedema-distichiasis§ Limb lymphedema, distichiasis, astigmatism, varicose veins, ptosis, heart
abnormalities
Unknown FOXC2
Kabuki§ Arched eyebrows, long palpebral fissures w/everted lower lids, flat
broadened nose, protruding earlobes, microcephaly, scoliosis, short fifth
fingers, fetal finger pads
1/32,000 KMT2D, KDM6A
Kallmann—Type 1, Type 2§ Hypogonadotropic hypogonaidism, lack of secondary sex characteristics,
anosmia, unilateral renal agenesis, hearing loss
1/10,000–86,000 KAL1 (Type 1),
FGFR1 (Type 2)
Larsen syndrome; atelosteogenesis§ Clubfoot, hip/knee/elbow dislocations, extra bones in wrists/ankles, blunt
and spatulate tips of fingers, scoliosis, frontal bossing, midface
hypoplasia, wide-set eyes, hearing loss
1/100,000 FLNB
Lethal and Escobar multiple
pterygium*
Pterygium, arthrogryposis, scoliosis, downslanting palpebral fissures,
epicanthal folds, small jaw, low-set ears
Unknown CHRNG
Loeys-Dietz, Types 1–4* Craniosynostosis, scoliosis, pectus excavatum/carinatum, clubfoot,
hypertelorism (bifid uvula and/or CP)
<1/1,000,000‡ TGFBR1, TGFBR2,
SMAD3, TGFB2
Miller* Malar hypoplasia, micrognathia, ectropion, lower eyelid coloboma,
microtia (CP ± CL)
30 cases reported DHODH
Oculofaciocardiodental* Microphthalmia, broad nasal tip, atrial/ventricular septal defect,
radiculomegaly
<1/1,000,000 BCOR
“Oro-facial-digital”§ Cleft tongue, broad flat nasal bridge, hypertelorism, syndactyly, (CP ± CL) 1/50,000–250,000 OFD1
Otopalatodigital Spectrum Disorders*: Hearing loss from ossicle malformations, skeletal abnormalities, prominent
brow ridges
FLNA
Type 1 Hypertelorism, downward-slanting eyes, small flat nose, Spatulate
fingertips
<1/100,000
Type 2 Hypertelorism, downward-slanting eyes, broad flat nose, micrognathia,
camptodactyly
<1/100,000
Frontometaphyseal dysplasia Joint contractures, bowed limbs, scoliosis, hypertelorism,
downward-slanting eyes, micrognathia
Few dozen cases
reported
Melnick-Needles Short stature, scoliosis, partial dislocation of joints,bowed limbs,
micrognathia, excess hair on forehead
<100 cases
reported
Pierre Robin Sequence* Micrognathia, glossoptosis, failure to thrive 1/8500–14,000 SOX9
PRS w/Campomelic dysplasia Bowing of leg bones, clubfoot, dislocated hips, ambiguous genitalia, small
chin, prominent eyes, flat face, glossoptosis, micrognathia,
laryngotracheomalacia
1/40,000–200,000 SOX9
PRS w/Stickler, Types 1–5 Flattened facial appearance, high myopia, abnormal vitreous, glaucoma,
cataracts, retinal detachment, hearing loss, hypermobile joints,
early-onset arthritis, scoliosis/kyphosis, platyspondyly
1/7500–9000 COL2A1, COL11A1,
COL11A2, COL9A1,
COL9A2
(Continued)
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TABLE 3 | Continued
Syndrome Other associated features Prevalence Gene(s)
Popliteal pterygium§ Pits near center of lower lip, missing teeth, webs of skin on backs of
knees, syndactyly, abnormal genitals (CP +/- CL)
1/300,000 IRF6
Saethre-Chotzen* Craniosynostosis, ptosis, hypertelorism, broad nasal bridge, facial
asymmetry, microtia
1/25,000–50,000 TWIST1
Smith-Lemli-Opitz§ Microcephaly, hypotonia, syndactyly, polydactyly 1/20,000–60,000 DHCR7
Snyder-Robinson† Delayed development, hypotonia, scoliosis/kyphosis, prominent lower lip 10 cases reported SMS
Treacher Collins* Micrognathia, downward-slanting eyes, lower eyelid coloboma, microtia 1/50,000 TCOF1, POLR1C,
POLR1D
Van der Woude§ Pits near center of lower lip, small mounds of tissue on lower lip (CP ± CL) 1/35,000–100,000 IRF6
X-linked cleft palate* ±Complete or partial ankyloglossia Unknown TBX22
X-linked intellectual disability:
Siderius type† Long face, sloping forehead, broad nasal bridge, upslanting palpebral
fissures, low-set ears, large hands
Few cases reported PHF8
Renpenning† Developmental delay, short stature, upslanting palpebral fissures,
shortened philtrum
60 cases reported PQBP1
All syndrome genes, associated features, and prevalences from Genetics Home Reference by the NIH unless otherwise specified (http://ghr.nlm.nih.gov/).
*Syndromes listed in Leslie and Marazita (2013).
§ Syndromes listed in Dixon et al. (2011).
†Syndromes listed in Genetics Home Reference by the NIH.
‡ Prevalence from Orphanet (http://www.orpha.net).
heart and kidney abnormalities, hearing loss, and developmental
delays (Burnside, 2015). DiGeorge patients may exhibit varying
severities of cleft palate, including a type known as Pierre
Robin Sequence (PRS), which presents with micrognathia and
a malpositioned tongue, resulting in a distinctive U-shaped cleft
palate (Brito et al., 2012). PRS is associated with mutations in a
number of genes, including SOX9 (Benko et al., 2009). Although
PRS is considered non-syndromic when it presents alone, it is
considered syndromic when it appears as a feature of other
syndromes, such as DiGeorge syndrome, Stickler syndrome, or
Campomelic dysplasia. These are among the major syndromes
associated with palatal clefting; many forms of syndromic cleft
palate have a prevalence of less than 1 out of 100,000, with only a
handful of cases reported in the literature for some. Additionally,
some conditions are caused primarily by de novo mutations
and lack any family history, in contrast to non-syndromic cleft
palate, which has a strong recurrence risk among affected families
(Rahimov et al., 2012; Setó-Salvia and Stanier, 2014).
Although many genome wide association studies (GWAS)
and linkage studies have been done on non-syndromic oral
clefts, most of them have focused on CL/P, identifying several
genes with common variants. Studies that have compared non-
syndromic CL/P with non-syndromic CPO found no association
betweenCPO and the candidate genes for CL/P, providing further
evidence that these two malformations have separate genetic
etiologies (Böhmer et al., 2013). At the time of writing, there
has been only one linkage study and two GWAS done solely on
non-syndromic CPO, although many GWAS, linkage, and other
association studies have been done on non-syndromic oral clefts
as a whole, which include CPO. The results from some of these
various studies are listed in Table 4.
The sole linkage study focusing exclusively on non-syndromic
CPO was performed using the DNA of 24 Finnish families, and
involved scanning all of chromosomes 2 and 4 and a candidate
TABLE 4 | Genetic risk factors for cleft palate.
Study Country SNP/nearby gene(s)
(chromosome)
OR (95% CI) or
p-value
LINKAGE STUDIES
Koillinen et al.,
2005
Finland 1p34 p = 0.069
2p24-p25 p = 0.016
12q21 p < 0.05
ASSOCIATION STUDIES
Pan et al., 2013 China rs742071 (1p36) 0.85 (0.36–2.03)
rs7590268 (2p21) 2.05 (1.07–3.91)
rs7632427 (3p11.1) 1.00 (0.61–1.64)
rs12543318 (8q21.3) 1.02 (0.68–1.52)
rs8001641 (13q31.1) 1.52 (0.95–2.43)
rs1873147 (15q22.2) 0.41 (0.20–0.86)
Butali et al., 2014b Africa c.493C > G (20q12) Not listed
Nikopensius et al.,
2010
Estonia rs17389541
(1q32.3-q41)
1.726 (1.263–2.358)
Latvia rs1793949 (12q13.11) 1.659 (1.235–2.229)
Lithuania rs11653738 (17q21) 1.518 (1.123–2.053)
Carter et al., 2010 Ireland rs3769817 (2q33.1) 1.45 (1.06–1.99)
rs2166975 (2p13.3) p = 0.041
Ghassibe-Sabbagh
et al., 2011
Europe, USA
Philippines
rs3827730 (1p32.3) p = 0.0003
region in 1p34 in both affected and unaffected family members,
along with a genome-wide scan of nine of the families with larger
pedigrees (Koillinen et al., 2005). Although no significant linkage
was found for any gene, the results showed suggestive linkage for
the loci 1p34, 2p24-p25, and 12q21, warranting further research
on these areas as candidate regions for cleft palate. Although
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the study found no mutations in IRF6, the gene responsible for
Van der Woude’s syndrome, more recent research has shown
that some genes responsible for syndromes involving cleft palate
may also be candidate genes for non-syndromic cleft palate, with
the most substantial evidence for the genes IRF6 and TBX22
(Marçano et al., 2004; Stanier and Moore, 2004; Zucchero et al.,
2004; Nikopensius et al., 2010; Rahimov et al., 2012; Pegelow
et al., 2014). In both of the GWAS on non-syndromic cleft palate,
no single SNP was significant when considered alone (Beaty et al.,
2011; Wu et al., 2014).
MATERNAL AND PATERNAL RISK
FACTORS
Although the risk factors for CL/P have been extensively
researched through epidemiologic and experimental studies, few
studies have focused exclusively on CPO. It is largely assumed
that the risk factors for CPO are the same as for CL/P. These
major risk factors include maternal exposure to tobacco smoke,
alcohol, and corticosteroids; folic acid deficiency; zinc deficiency;
and maternal grief. More recent research has differentiated
between CPO and CL/P when analyzing their risk factors, and
the odds ratios for CPO from some of these studies are listed in
Table 5.
Maternal exposure to tobacco smoke has been reported
as the strongest risk factor for CPO. The most commonly
reported odds ratio from one meta-analysis is 1.22, but a more
recent study found an odds ratio of 1.38, with both studies
comparing any tobacco smoke exposure against none at all (Little
et al., 2004; Butali et al., 2013a). However, these values may
be underestimated as most studies only assess active maternal
tobacco use and not passive smoke exposure or paternal smoking
(Mossey et al., 2009). This has been further evidenced by a meta-
analysis on passive smoking which found an odds ratio of 2.11 for
non-syndromic CPO (Sabbagh et al., 2015).
Although folic acid deficiency has been found to cause cleft
palate in animal models, including a protective effect of folic acid
supplements against trans-retinoic acid-induced cleft palate in
mouse models (Yao et al., 2011), data on folate use and risk of
cleft palate in humans have been inconclusive. Several clinical
studies on maternal use of folate and risk of CPO showed no
significant association between the two (Johnson and Little, 2008;
Little et al., 2008; Li et al., 2012; Butali et al., 2013a), with one
study reporting an odds ratio of 0.95 with folic acid use (Johnson
and Little, 2008). However, these inconsistencies may partially
be due to differences in methods of ascertainment for folic acid
intake, as folic acid is available through dietary folate, folic acid
supplements, or multivitamins with folic acid (Li et al., 2012).
Some studies differentiate between these different forms while
others do not, which may cause inconsistencies in the data if the
dose of folic acid varies greatly between women. Additionally,
even though there has been a reported decrease in oral clefts in
North America since the mandatory fortification of grains with
folic acid in the late 1990’s (Parker et al., 2010; Saad et al., 2014),
this decline is seen only in CL/P, while CPO rates have remained
fairly constant (Johnson and Little, 2008).
Clinical studies on maternal alcohol consumption as a risk
factor for CPO have been inconsistent as well (Meyer et al.,
2003; Chevrier et al., 2005; Bille et al., 2007; Romitti et al., 2007),
even though it has been shown in animal models to have a
disruptive effect on neural crest cells, which contribute to lip and
palate development (Bell et al., 2014). In one meta-analysis which
stratified by the amount of alcohol consumption, the odds ratios
only slightly varied, with 0.94 for binge drinking and 1.05 for
any alcohol exposure (Bell et al., 2014). However, this seemingly
low odds ratio and discrepancies between studies may be due
to underreporting of alcohol use by mothers, as most people
tend to underestimate how much they drink or overestimate the
volume of “one drink.” More thorough studies still need to be
done to establish maternal alcohol use as a risk factor for CPO,
but obtaining accurate data may be difficult due to this recall bias.
Zinc is crucial to normal fetal development, especially in the
central nervous system, and maternal deficiency has been shown
to cause cleft palate in animal models (Hurley and Swenerton,
1966; Warkany and Petering, 1972; Quinn et al., 1990; Mossey
et al., 2009). Although maternal zinc deficiency has been shown
as a risk factor for oral clefts in human studies, data is still limited
for CPO as most studies have analyzed CL/P (Krapels et al.,
2004; Shah and Sachdev, 2006; Hozyasz et al., 2009); only two
studies have examined CPO and maternal plasma zinc levels. In
the Philippines, women with plasma zinc levels of 9.0–9.8 and
9.9–10.9µmol/L had odds ratios of 0.65 and 0.27, respectively,
and 94% of mothers of children with CPO were found to have
low plasma zinc levels (defined as < 11.0µmol/L) (Tamura et al.,
2005). In Utah, for non-syndromic CPO, mothers with plasma
zinc levels of 9.3–10.4 and 10.4–11.6µmol/L had odds ratios of
0.75 and 0.78, respectively; for CPOwithmalformations, mothers
with plasma zinc levels of 9.3–10.4 and 10.4–11.6µmol/L had
odds ratios of 1.03 and 1.20, respectively (Munger et al., 2009).
When directly comparing the two studies, the odds ratios were
not as significant in Utah as in the Philippines; however, maternal
plasma zinc levels overall were higher in Utah, suggesting that
maternal zinc deficiency may not be a strong risk factor unless
it is severely compromised (Munger et al., 2009). Even though
maternal zinc deficiency has been correlated with CPO in animal
studies and with CL/P in humans, more clinical research is still
needed to determine if low maternal zinc levels are a risk factor
for CPO.
Other risk factors significant for CPO are corticosteroid use
and bereavement in the antenatal period. In one study on
oral nonsystemic corticosteroid use, syndromic CPO and any
corticosteroid use had an odds ratio of 1.68, with an even higher
odds ratio of 3.38 for dermatologic corticosteroids (Skuladottir
et al., 2014). For non-syndromic CPO, all corticosteroid use had
an odds ratio of 1.30, with dermatologic corticosteroids having an
odds ratio of 2.64 (Skuladottir et al., 2014). For both syndromic
and non-syndromic CPO, these odds ratios are more significant
than those of smoking, folic acid deficiency, andmaternal alcohol
use. In a study on bereavement during the antenatal period
(defined as the death of a close relative), an odds ratio of 1.34 was
found for non-syndromic CPO; when male and female offspring
were calculated separately, the odds ratios were 1.83 and 0.91,
respectively; and when stress was due to the death of a child,
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TABLE 5 | Maternal risks factors associated with cleft palate.
Risk factor Study Country Categories OR (95% CI)
Smoking Little et al., 2004 Various Smoking vs. none 1.22 (1.1–1.35)
Leite et al., 2014 Denmark Smoking vs. none 1.09 (0.88–1.35)
Butali et al., 2013a Europe Smoking vs. none 1.38 (1.04–1.83)
Sabbagh et al., 2015 Various Passive smoking exposure vs. none 2.11 (1.23–3.62)
Supplements Butali et al., 2013a Europe Folic acid use vs. none 1.18 (0.89–1.57)
Johnson and Little, 2008 Europe, North America,
South America,
Australia, Asia
Any supplement use vs. none 0.88 (0.76–1.01)
Multivitamins vs. none 0.88 (0.74–1.04)
Folic acid supplements vs. none 0.95 (0.79–1.14)
Preconceptionally start vs. none 0.70 (0.51–0.98)
After 4th month of gestation vs. none 0.99 (0.71–1.38)
Alcohol Bell et al., 2014 USA, Australia, Europe,
India, Brazil, Japan,
Canada
Any alcohol use vs. no/low alcohol use 1.05 (0.92–1.21)
Alcohol use during 1st trimester vs. no/low alcohol 1.05 (0.90–1.23)
Alcohol use during pregnancy vs. no/low alcohol 1.06 (0.75–1.48)
Binge drinking vs. no/low alcohol (1st trimester) 0.94 (0.74–1.21)
Romitti et al., 2007 USA 1–4 drinks/mo vs. none 1.3 (1.0–1.9)
5–15 drinks/mo vs. none 1.1 (0.8–1.7)
16–30 drinks/mo vs. none 1.1 (0.6–1.8)
>30 drinks/mo vs. none 1.1 (0.6–2.2)
Diabetes mellitus Correa et al., 2008 USA Pregestational DM vs. none 1.80 (0.67–4.87)
Gestational DM vs. none 1.54 (1.01–2.37)
Bánhidy et al., 2010 Hungary DM Type 1 vs. none 2.2 (0.7–6.8)
DM Type 2 vs. none 0.4 (0.1–3.2)
Gestational DM vs. none 0.3 (0.0–2.0)
Obesity Stott-Miller et al., 2010 Washington Non-syndromic CP:
Overweight vs. normal weight 0.92 (0.69–1.22)
Obese vs. normal weight 1.21 (0.85–1.72)
All types of CP:
Overweight vs. normal weight 0.84 (0.66–1.08)
Obese vs. normal weight 1.04 (0.76–1.42)
Block et al., 2013 Florida Pre-pregnancy BMI: underweight vs. normal 1.27 (0.91–1.77)
Pre-pregnancy BMI: Overweight vs. normal 0.97 (0.79–1.20)
Pre-pregnancy BMI: Obese vs. normal 1.32 (1.07–1.62)
Stothard et al., 2009 Various Obese vs. recommended BMI 1.23 (1.08–1.47)
Overweight vs. recommended BMI 1.02 (0.86–1.20)
Izedonmwen et al., 2015 Various Obese vs. normal weight 1.14 (0.95–1.37)
Overweight vs. normal weight 0.89 (0.75–1.06)
Nonsystemic
corticosteroid use
Skuladottir et al., 2014 Norway Syndromic CP:
All CST vs. none 1.68 (0.71–3.98)
Dermatologic CST use vs. none 3.38 (0.87–13.09)
Non-dermatologic CST use vs. none 1.08 (0.34–3.40)
Non-syndromic CP:
Any type of CST use vs. none 1.30 (0.42–4.05)
Dermatologic CST use vs. none 2.64 (0.49–14.31)
Non-dermatologic CST use vs. none 0.83 (0.18–3.91)
(Continued)
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TABLE 5 | Continued
Risk factor Study Country Categories OR (95% CI)
Bereavement in
antenatal period
Ingstrup et al., 2013 Denmark Bereavement vs. none 1.34 (0.87–2.04)
All types of bereavement vs. none 0.91 (0.45–1.82)
Sudden death vs. none 1.69 (0.63–4.51)
Death of a child vs. none 2.36 (1.09–4.92)
Environmental
conditions
Chung et al., 2013 China (Hong Kong) Sunshine at conception vs. none P = 0.30
Sunshine at 4 weeks vs. none P = 0.072
Sunshine at 8 weeks vs. none P = 0.009
NOx at conception vs. none P = 0.506
NOx at 4 weeks vs. none P = 0.794
NOx at 8 weeks vs. none P = 0.343
NO at conception vs. none P = 0.127
NO at 4 weeks vs. none P = 0.795
NO at 8 weeks vs. none P = 0.085
Organic solvents Desrosiers et al., 2012 USA Chlorinated vs. none 0.83 (0.50–1.38)
Stoddard vs. none 1.45 (0.72–2.87)
Aromatic vs. none 1.03 (0.49–2.20)
Zinc (plasma
levels)
Munger et al., 2009 Utah Isolated CP:
9.3–10.4 vs. ≤9.2µmol/L 0.75 (0.36–1.57)
10.4–11.6 vs. ≤9.2µmol/L 0.78 (0.39–1.54)
≥11.7 vs. ≤9.2µmol/L 0.93 (0.47–1.84)
CP with Malformations:
9.3–10.4 vs. ≤ 9.2µmol/L 1.03 (0.44–2.40)
10.4–11.6 vs. ≤9.2µmol/L 1.20 (0.55–2.65)
≥11.7 vs. ≤9.2µmol/L 0.67 (0.27–1.67)
Tamura et al., 2005 Philippines 9.0–9.8 ≤ 8.9µmol/L 0.65 (0.16–2.68)
9.9–10.9 ≤ 8.9µmol/L 0.27 (0.05–1.45)
≥ 11.0 ≤ 8.9µmol/L 0.07 (0.01–0.73)
the odds ratio was 2.36 (Ingstrup et al., 2013). This correlation
of bereavement during the antenatal period and increased risk
of oral clefts is thought to be due to the fact that stress causes
increased levels of cortisol, which is a corticosteroid. Although
more research is needed in this area, maternal exposure to
corticosteroids of endogenous or iatrogenic origin alike has been
shown to be a potential risk factor for CPO.
More recently, obesity and diabetes mellitus have been
recognized as risk factors for cleft palate. Animal studies have
shown that pregnant mice fed high-fat diets have a higher rate
of offspring with cleft palates (Kappen, 2013). In a large case-
control study of mothers who had pregestational (PGDM) or
gestational diabetes mellitus (GDM) and children with birth
defects, odds ratios of 1.80 and 1.54 were found for mothers
of children with CPO who had PGDM or GDM, respectively
(Correa et al., 2008). A similar study from Hungary found odds
ratios of 2.2, 0.4, and 0.3 for mothers with DM Type 1, DM
Type 2, and GDM, respectively (Bánhidy et al., 2010). Other
research has also found an increased risk of CPO in children
of women who had a pre-pregnancy body mass index of 30
or higher (Mandal et al., 2011; Block et al., 2013). A case-
control study on mothers who were obese pre-pregnancy found
an odds ratio of 1.21 for non-syndromic CPO and 1.04 for all
forms of CPO (Stott-Miller et al., 2010). A systematic review
and meta-analysis by Stothard et al. found an odds ratios of 1.23
for pre-pregnancy obesity and all forms of CPO, and a similar
study by Izedonmwen et al. found an odds ratio of 1.14 (Stothard
et al., 2009; Izedonmwen et al., 2015). Although the mechanism
by which obesity may contribute to cleft palate is still unknown,
it is hypothesized it may be due to nutritional deficiencies or
to alterations in glycemic control, similar to those experienced
by diabetic mothers (Izedonmwen et al., 2015). One study has
shown changes in lipid metabolism in mice with aberrant TGF-
β signaling contribute to cleft palate formation, indicating a
potential mechanistic link between diabetes mellitus and cleft
palate (Iwata et al., 2014). Even though clinical studies have been
fairly consistent in their findings for diabetes mellitus and obesity
as risk factors for CPO, more research is still needed on the
pathophysiology of this process.
Paternal risk factors for CPO have not been thoroughly
researched, with the majority of studies focusing on advanced
paternal age (Green et al., 2010; Bell et al., 2014; Ma et al., 2015).
In a large study on congenital malformations in Poland, an odds
ratio of 1.11 was found with increasing paternal age every 5 years
(Materna-Kiryluk et al., 2009), and a meta-analysis on parental
age and oral clefts found a 58% higher probability of CPO in
children of fathers 40 years and older (Herkrath et al., 2012).
Krapels et al. performed one of the largest questionnaire studies
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to date on several paternal risk factors, finding odd ratios of
1.5 for smoking, 1.8 for alcohol use, 0.6 for coffee use, 0.5 for
medication use, and 0.2 for allergies (Krapels et al., 2006). Besides
older paternal age, it is still unclear if paternal factors increase the
risk of cleft palate formation.
GENE-ENVIRONMENT (GXE)
INTERACTIONS
Several study designs have been implemented to examine the
possible role of interactions of environmental teratogens with
genetic mutations on cleft palate formation. Skare et al. analyzed
case-parent trios against control-parent trios, using known
candidate genes for cleft palate, and found a potential interaction
between TBX4 (chromosome 17q21-q22) and dietary folate
(Skare et al., 2012). A meta-analysis was performed by Zeiger
et al. on oral clefts and maternal smoking, which found an odds
ratio of 1.95 for the transforming growth factor alpha (TGFA)
TaqI C2 allele and CPO (Zeiger et al., 2005).
To date, only two GWAS have analyzed gene mutations
and environmental interactions for non-syndromic CPO. Beaty
et al. analyzed a gene’s risk based on maternal exposure to
three common environmental risk factors, using an international
consortium of 550 case-parent trios (Beaty et al., 2011). Although
no single SNP was significant when considered without maternal
exposure, certain SNPs in several loci showed a strong association
with CPOwhenGxE interactions withmaternal smoking, alcohol
use, and vitamin use were included. For maternal smoking,
several SNPs reached genome-wide significance in the genes
MLLT3 and SMC2, both on chromosome 9, and OBSCN on
chromosome 1q42.13. For maternal alcohol use, SNPs were
found to reach genome-wide significance in the genes TBK1
on chromosome 12q14.2 and ZNF236 on chromosome 18q22-
q23. SNPs in genes BAALC on chromosome 8q22.3 and ACOXL
on chromosome 2q13 were found to have a greater protective
effect with maternal vitamin use. Wu et al. performed a similar
GWAS stratifying trios into Asian and European ancestry (Wu
et al., 2014). Several SNPs in the genes SLC2A9 andWDR1, both
on chromosome 4p16.1, in the Asian trios approached genome-
wide significance when maternal environmental tobacco smoke
exposure was considered. The most significant SNPs included
rs3733585 and rs12508991 in SLC2A9 (p = 2.26 × 10−7 and
2.26 × 10−7) and s6820756 and rs7699512 in WDR1 (p =
1.79×10−7 and 1.98×10−7, respectively). Although chromosome
4p16.1 has been implicated as an additional contributor to non-
syndromic CL/P, the candidate genes found on chromosomes
1, 2, 8, 9, 12, and 18 are all distinct from those found in
GWAS of non-syndromic CL/P (Beaty et al., 2010; Butali et al.,
2013b), further suggesting that CL/P and CPO are separate
malformations.
MORBIDITY AND MORTALITY
Children born with oral clefts have been shown to have higher
mortality rates, especially in the presence of other birth defects
(Vallino-Napoli et al., 2006; Carlson et al., 2013). Kang et al.
found a 15 times greater risk of mortality in CPO patients when
compared to the general population, and a 10 times greater risk
when compared to other types of clefts (Kang et al., 2012). A
14-year study of Dutch patients found an infant mortality rate
(IMR) of 2.45% for all CPO, with the most common cause of
death for all oral clefts being congenital malformations of the
heart (40.6%; van Nunen et al., 2014). Congenital heart defects
commonly present with oral clefts, and are reported to occur in
1.3 to 27% of affected individuals, although the mechanism is still
unknown (Setó-Salvia and Stanier, 2014).
Epidemiological studies have assessed the relationship
between cancer and clefts. Bille et al. found an increased risk
of breast cancer and primary brain cancer in females with
cleft palate (Bille et al., 2005), while Lima et al. found breast,
colorectal, stomach, prostate, and uterine cancers to be the most
common among those with oral clefts (Lima et al., 2013). Recent
research has also shown differences in cerebellar morphology
in patients with oral clefts. DeVolder et al. found that males
with cleft palate had regional changes in the cerebellum but not
reductions in volume, while females with cleft palate had reduced
cerebellum volumes (DeVolder et al., 2013).
TREATMENT
Multidisciplinary care is needed to provide comprehensive
treatment for CPO beginning at birth and spanning until
adulthood. Care for children born with these defects includes
plastic surgery, nursing, maxillofacial surgery, otolaryngology,
speech therapy, audiology, psychological counseling, genetic
testing and counseling, dentistry, and orthodontics. While each
cleft center has developed its own team approach and sequence of
care, typical management involves the following, described here
briefly.
Surgical Treatment and Complications
Unlike the artistic nature of the cleft lip repair, the cleft palate
repair is very functional in nature. The goal of the surgery
certainly includes closure of the defect, but mostly focuses on
quality of speech (Agrawal, 2009). Multiple different methods
of repair have been demonstrated and improved throughout the
years, focusing on either lengthening of the palate, alignment of
the muscle or both (Strong and Buckmiller, 2001). Soft palate
repair techniquesmay be used in isolation or combined with hard
palate procedures, as necessary. Most surgeons today perform
either some modification of an intravelar veloplasty, vs. a two-
flap palatoplasty with double opposing z-plasty to achieve levator
muscular repositioning (Sitzman and Marcus, 2014). Overall, the
goals of palate repair are separating the oral and nasal cavity
and creating a competent velopharyngeal valve for swallowing
and speech, while preserving midface growth and development
of functional occlusion (Friedman et al., 2010).
The timing of repair is also debated, and has ranged from
shortly after birth to as late as 6 years of life. Much of the
controversy against the early repair centers on inhibition of facial
growth, in contrast to the late repair, which is met with significant
restrictions in clear speech. Today, most cleft surgeons focus
on the type of repair to be performed in a period somewhere
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between 9 and 18 months of age. The palate repair technique and
timing chosen by each surgeon is heavily reliant on their training,
comfort and preference given the lack of long-term evidence
of efficacy and outcomes. A 2007 survey of 306 American
cleft surgeons showed that 96% perform one-stage repairs and
85% perform palate surgery when the patient is between 6
and 12 months of age. Evidence suggests that children do not
benefit from palate repair after age seven, as significant speech
abilities have already developed and changing the anatomy at this
stage may hinder speech progress. Early interventions such as
nasoalveolar molding, presurgical orthopedics, external taping,
and gingivoperiosteoplasty are newer advances that aim to
minimize the number of surgeries needed and optimize surgical
results by repositioning bony and soft tissue structures prior to
an infant’s first palate surgery (Hopper et al., 2006).
Immediate complications of cleft palate repair are bleeding,
respiratory obstruction, infection, and dehiscence. Bleeding and
respiratory obstruction happen immediately after surgery, and
while rare require re-intubation and may be life-threatening
(Hopper et al., 2006). Palatal (oronasal) fistulas may also form,
ranging from asymptomatic holes to large communications
between the oral and nasal cavities that cause speech problems,
nasal regurgitation and hygiene difficulties. If symptomatic,
fistulas may be surgically corrected with local mucosal flaps
(Katzel et al., 2009). Factors that affect fistula formation include
the anatomy of the cleft (primary palate clefts have higher fistula
rates), the type of repair, and the experience level of the surgeon
(Hopper et al., 2006).
Long-Term Treatment
Even though repairing the cleft palate itself may be a one-time
operation, treating the resulting dental and speech problems,
along with the associated psychological implications, is a long-
term effort usually not fully completed until the late teenage
years (Setó-Salvia and Stanier, 2014). Much of the debate
regarding long-term outcomes of cleft repairs is centered on
speech development and growth of the mid-face. Inadequate
repair of the palatal muscles or inadequate length of the soft
palate after palatoplasty may result in a structural defect or
physiologic dysfunction of the velopharyngeal valve, resulting
in the most common speech deficiency after cleft palate
repair: velopharyngeal insufficiency (VPI). The inability to
completely separate the oral and nasal cavities during speech
leads to hypernasality, nasal emission, imprecise consonant
pronunciation, decreased vocal loudness, and speaking in short
phrases (Hopper et al., 2006). In a study on the health-related
quality of life (HRQL) of children with oral clefts, researchers
found that HRQL decreased as severity of speech problems
increased, and older children with CPO had lower HRQL than
those with CL/P (Damiano et al., 2007). Monitoring for early
VPI can be done through speech therapy and nasopharyngoscopy
both before and after palate surgery (Chen and Kane, 2012).
Surgical options for improving VPI are a pharyngeal flap or
sphincter pharyngoplasty.
Decreased maxillary width and crossbite may be treated with
orthodontic expansion combined with bone grafting. Midface
hypoplasia (restricted growth of the mid-face) often results in an
Angle Class III occlusion (underbite) and may be treated with a
distraction device and eventual surgery to advance the midface
(LeFort I maxillary orthognathic advancement) (Hopper et al.,
2006).
FUTURE DIRECTIONS FOR RESEARCH
Five main themes emerge as critical in advancing research in
CPO: (1) monitoring of the occurrence of CPO across different
parts of world to assess prevalence and availability of health
care services (capacity building); (2) detailed phenotyping of
the severity of CPO in relation to timing in embryogenesis and
potential genetic/environmental factors that can impair closure
(biology); (3) understanding of the genetic and environmental
risk factors for CPO and their interaction (primary prevention);
(4) access to early detection and multidisciplinary treatment of
children with CPO from birth into adulthood (clinical services);
and (5) understanding predictors of recurrence and possible
interventions to lower risk among mothers of reproductive age
(secondary prevention). In all five areas, it will be important
to distinguish between CPO and CL/P in order to address
potential differences, which will present challenges given the
rarity and less obvious nature of CPO. This will necessitate
large consortium efforts globally to attain a large enough sample
size to evaluate CPO-specific genetic and environmental risk
factors, multidisciplinary approaches to treatment and predictors
of future recurrence in parents with at least one affected
child.
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